![Procedural outcomes in patients with dual versus single antiplatelet therapy prior to transcatheter aortic valve replacement | Scientific Reports Procedural outcomes in patients with dual versus single antiplatelet therapy prior to transcatheter aortic valve replacement | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-94599-2/MediaObjects/41598_2021_94599_Fig1_HTML.png)
Procedural outcomes in patients with dual versus single antiplatelet therapy prior to transcatheter aortic valve replacement | Scientific Reports
![Anti-thrombogenic coatings for devices in neurointerventional surgery: Case report and review of the literature | Semantic Scholar Anti-thrombogenic coatings for devices in neurointerventional surgery: Case report and review of the literature | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/31b7f983882dcad961dab756f98235518e05456c/3-Figure1-1.png)
Anti-thrombogenic coatings for devices in neurointerventional surgery: Case report and review of the literature | Semantic Scholar
![PDF] Recommendations for the management of lower extremity artery disease (LEAD) based on ESVS/ /ESC 2017 guidelines. Position document of PTChN, PTNT, PTLR and SFSN PTK experts | Semantic Scholar PDF] Recommendations for the management of lower extremity artery disease (LEAD) based on ESVS/ /ESC 2017 guidelines. Position document of PTChN, PTNT, PTLR and SFSN PTK experts | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/456b9a949193c0912c985ed0562d1010699dd432/22-Table21-1.png)
PDF] Recommendations for the management of lower extremity artery disease (LEAD) based on ESVS/ /ESC 2017 guidelines. Position document of PTChN, PTNT, PTLR and SFSN PTK experts | Semantic Scholar
![JCM | Free Full-Text | Antithrombotic Treatment Patterns of Patients with Symptomatic Peripheral Arterial Occlusive Disease in Germany: Evidence from Health Insurance Claims Data JCM | Free Full-Text | Antithrombotic Treatment Patterns of Patients with Symptomatic Peripheral Arterial Occlusive Disease in Germany: Evidence from Health Insurance Claims Data](https://www.mdpi.com/jcm/jcm-11-05455/article_deploy/html/images/jcm-11-05455-g001-550.jpg)
JCM | Free Full-Text | Antithrombotic Treatment Patterns of Patients with Symptomatic Peripheral Arterial Occlusive Disease in Germany: Evidence from Health Insurance Claims Data
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the
![Frontiers | Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction Frontiers | Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction](https://www.frontiersin.org/files/MyHome%20Article%20Library/783344/783344_Thumb_400.jpg)
Frontiers | Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction
![Cumulative incidence of clinical outcomes according to antiplatelet... | Download Scientific Diagram Cumulative incidence of clinical outcomes according to antiplatelet... | Download Scientific Diagram](https://www.researchgate.net/publication/356650778/figure/fig5/AS:1097697746526214@1638722945969/Central-illustration-of-this-study-SAPT-single-antiplatelet-therapy-DAPT-dual_Q320.jpg)
Cumulative incidence of clinical outcomes according to antiplatelet... | Download Scientific Diagram
![Systemic embolism in oral anti-coagulation alone therapy (OAC) alone... | Download Scientific Diagram Systemic embolism in oral anti-coagulation alone therapy (OAC) alone... | Download Scientific Diagram](https://www.researchgate.net/publication/356761444/figure/fig2/AS:1098489605959695@1638911739577/Systemic-embolism-in-oral-anti-coagulation-alone-therapy-OAC-alone-versus-oral.png)
Systemic embolism in oral anti-coagulation alone therapy (OAC) alone... | Download Scientific Diagram
![Long-Term P2Y12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention | Circulation Long-Term P2Y12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention | Circulation](https://www.ahajournals.org/cms/asset/58a785ee-e24b-40bc-9bed-17fad2c5ee0e/circulationaha.122.063004.fig01.jpg)
Long-Term P2Y12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention | Circulation
![Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches](https://www.frontiersin.org/files/Articles/805525/fcvm-09-805525-HTML/image_m/fcvm-09-805525-g001.jpg)
Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches
![Initial report of percutaneous left atrial appendage closure in hemodialysis patients with atrial fibrillation and high risk of bleeding in Japan | SpringerLink Initial report of percutaneous left atrial appendage closure in hemodialysis patients with atrial fibrillation and high risk of bleeding in Japan | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12928-022-00904-9/MediaObjects/12928_2022_904_Fig2_HTML.png)
Initial report of percutaneous left atrial appendage closure in hemodialysis patients with atrial fibrillation and high risk of bleeding in Japan | SpringerLink
Dual antiplatelet therapy in patients with a long coronary artery lesion over 30mm: Determinants and impact on prognosis
![Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens - ScienceDirect Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167527322014164-ga1.jpg)
Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens - ScienceDirect
![Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719352088-fx1.jpg)